CRL Chief Scientific Officer Dr. Robert Stout discusses the lasting impact of COVID-19 infection in both symptomatic and asymptomatic patients…. Read More
Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Dr. Steven J. Rigatti explores marijuana use during the COVID-19 pandemic as a follow-up to earlier commentary on alcohol and tobacco use…. Read More
Delta-8 Compound Marijuana testing is used by a number of life insurers in the risk assessment process. New chemical entities… Read More
See below for details on the latest CRL acquisition. We are pleased to share that CRL has acquired Confirm BioSciences, a… Read More
Learn about our electronic lab slip products including eSlip and SecureSlip, and why you should implement digital workflow automation today. … Read More
As COVID-19 continues to be top of mind, we are committed to serving our customers and understanding the virus. There… Read More
Epigenetic testing is a critical part of CRL’s approach to innovative science. Read below to learn about how epigenetic testing… Read More